Status:
RECRUITING
Application of Patient Blood Management in the Oncology Patient Affected by Breast Cancer
Lead Sponsor:
Regina Elena Cancer Institute
Collaborating Sponsors:
Campus Bio-Medico University
Umberto I Hospital, Frosinone Italy
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
Evaluation of the percentage of transfusions in patients with breast cancer undergoing surgery after preventive treatment with haematinics.
Detailed Description
Preoperative anemia treatment is fundamental in Patient Blood Management (PBM) programs, a multidisciplinary and multimodal strategy that improves clinical outcomes based on the patient's blood resour...
Eligibility Criteria
Inclusion
- age \> 18 years;
- patients diagnosed with histologically confirmed breast cancer and whether or not they have undergone neoadjuvant chemotherapy;
- patients who are candidates for destructive and reconstructive breast surgery or not;
- Hb values less than or equal to 11 g/dL and/or transferrin saturation less than or equal to 20%;
- written informed consent.
Exclusion
- patients with known allergies to ferric carboxymaltose or its excipients;
- ferritin values greater than 500 ng/ml;
- patients unable to sign consent and comply with procedures.
Key Trial Info
Start Date :
January 31 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2025
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT06883201
Start Date
January 31 2023
End Date
June 30 2025
Last Update
March 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
"Regina Elena" National Cancer Institute
Rome, Italy, 00144